The British pharmaceutical company said it will pay $875 million to the Spanish drug maker Almirall and up to $1.22 billion more for various development and sales-related milestones.
via NYT > Business Day http://ift.tt/UKpyCo
via WordPress http://ift.tt/1uGlF27
No comments:
Post a Comment